Global Compounding Pharmacy Market Growth (Status and Outlook) 2023-2029

Global Compounding Pharmacy Market Growth (Status and Outlook) 2023-2029

Product Code:456181

Published Date: Feb 08,2023

Pages: 121

Region: Global

Category: Pharma & Healthcare

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example:
A young child may need a small, liquid dose of a drug made only in adult-dosage tablets.

A person may be allergic to one of the ingredients in the commercial version of a drug.

A compounding pharmacy would make the proper dosage and form of the drug without any offending ingredients.

Compounded medications are made based on a practitioner’s prescription in which individual ingredients are mixed together in the exact strength and dosage form required by the patient. This method allows the compounding pharmacist to work with the patient and the prescriber to customize a medication to meet the patient’s specific needs.

LPI (LP Information)' newest research report, the “Compounding Pharmacy Industry Forecast” looks at past sales and reviews total world Compounding Pharmacy sales in 2022, providing a comprehensive analysis by region and market sector of projected Compounding Pharmacy sales for 2023 through 2029. With Compounding Pharmacy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Compounding Pharmacy industry.

This Insight Report provides a comprehensive analysis of the global Compounding Pharmacy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Compounding Pharmacy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Compounding Pharmacy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Compounding Pharmacy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Compounding Pharmacy.

The global Compounding Pharmacy market size is projected to grow from US$ 11320 million in 2022 to US$ 13730 million in 2029; it is expected to grow at a CAGR of 2.8% from 2023 to 2029.

Global Compounding Pharmacy key players include Fagron, Wedgewood Pharmacy, CAPS, Fresenius Kabi, Advanced Pharma, etc. Global top five manufacturers hold a share nearly 5%.

North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent. 
In terms of product, PIA is the largest segment, with a share over 30%. And in terms of application, the largest application is Consumers Aged 45 to 64, followed by Consumers Aged 65 and Older, Consumers Aged 19 to 44, Consumers Aged 18 and Younger.

This report presents a comprehensive overview, market shares, and growth opportunities of Compounding Pharmacy market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
    PIA
    PAA
    CUPM
    PDA
    SAPM

Segmentation by application
    Consumers Aged 18 and Younger
    Consumers Aged 19 to 44
    Consumers Aged 45 to 64
    Consumers Aged 65 and Older

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    PharMEDium Services
    B. Braun Group
    Fagron
    Wedgewood Pharmacy
    New Compounding Pharma
    Medisca
    Fresenius Kabi
    Advanced Pharma
    AIN GROUP
    Nihon Chouzai
    Sogo Medical
    Dougherty’s Pharmacy
    Apollo Pharmacy
    Downing Labs
    Qol Holdings
    Olympia Pharmacy
    PUMCH
    Triangle Compounding Pharmacy
    Peking University First Hospital
    Affiliated Hospital of Guangdong Public Institution of Medicine
    Lorraine's Pharmacy
    PLAGH
    Institutional Pharmacy Solutions
    Ruijin Hospital
    Belle Sante
    Byculla Pharmacy&Stores
    Royal Chemists
    Village Compounding Pharmacy
    Specialist Pharmacy